DYN

Dyne Therapeutics Inc (DYN)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 1.87B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 37.08
52W Low
$ 6.36
Dividend Yield
0.00%
Beta
1.10

Technicals

50-Day MA
11.1141
200-Day MA
14.0632
52 Week High
37.08
52 Week Low
6.36

About DYN

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

Employees
206
Headquarters
Waltham, MA
CEO
Mr. John G. Cox M.B.A.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg